Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Traws Pharma, Inc. (TRAW) had Return on Tangible Equity of 235.84% for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$0.00M |
|
$-4.56M |
|
-- |
|
$0.00M |
|
$7.37M |
|
$-7.37M |
|
$-0.07M |
|
$-7.44M |
|
$-7.44M |
|
$-7.44M |
|
$-7.44M |
|
$-7.44M |
|
$-7.44M |
|
$-7.37M |
|
$-7.32M |
|
8.23M |
|
8.38M |
|
$-0.89 |
|
$-0.82 |
|
| Balance Sheet Financials | |
$7.98M |
|
$0.01M |
|
$2.64M |
|
$10.62M |
|
$11.15M |
|
-- |
|
$0.10M |
|
$11.25M |
|
$-0.63M |
|
$-3.16M |
|
$-0.63M |
|
9.07M |
|
| Cash Flow Statement Financials | |
$-18.18M |
|
$-2.58M |
|
$3.20M |
|
$21.34M |
|
$3.82M |
|
$-17.52M |
|
$0.73M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.72 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-18.18M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
0.00 |
|
-- |
|
1183.29% |
|
|
Return on Tangible Equity |
235.84% |
-70.10% |
|
1183.31% |
|
$-0.07 |
|
$-2.17 |
|
$-2.17 |
|